Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07123402 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia

Study acronym: TRD205
StatusEnrolling by Invitation
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 17, 2025 (before its estimated April 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary endpoint revisedv2 See this version in full on ClinicalTrials.gov ↗
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a phase II, multicenter ,randomized, double-blind, placebo-controlled, dose-finding study designed to evaluate the efficacy and safety of TRD205 tablets in the treatment of chronic postoperative neuralgia
Trial Details
NCT Number NCT07123402
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Collaborators: China-Japan Friendship Hospital
Conditions Chronic Postoperative Neuralgia
Enrollment 184 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov